Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway

Abstract Background Esophageal squamous cell carcinoma (ESCC) is the most predominant primary malignant tumor among worldwide, especially in China. To date, the successful treatment remains a mainly clinical challenge, it is imperative to develop successful therapeutic agents. Methods The anti-proli...

Full description

Bibliographic Details
Main Authors: Nana Xu, Mengmeng Lu, Jiaxin Wang, Yujia Li, Xiaotian Yang, Xiajie Wei, Jiaoyang Si, Jingru Han, Xiaojuan Yao, Juanmei Zhang, Junqi Liu, Yanming Li, Hushan Yang, Dengke Bao
Format: Article
Language:English
Published: BMC 2021-12-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-09021-x
_version_ 1818461598469062656
author Nana Xu
Mengmeng Lu
Jiaxin Wang
Yujia Li
Xiaotian Yang
Xiajie Wei
Jiaoyang Si
Jingru Han
Xiaojuan Yao
Juanmei Zhang
Junqi Liu
Yanming Li
Hushan Yang
Dengke Bao
author_facet Nana Xu
Mengmeng Lu
Jiaxin Wang
Yujia Li
Xiaotian Yang
Xiajie Wei
Jiaoyang Si
Jingru Han
Xiaojuan Yao
Juanmei Zhang
Junqi Liu
Yanming Li
Hushan Yang
Dengke Bao
author_sort Nana Xu
collection DOAJ
description Abstract Background Esophageal squamous cell carcinoma (ESCC) is the most predominant primary malignant tumor among worldwide, especially in China. To date, the successful treatment remains a mainly clinical challenge, it is imperative to develop successful therapeutic agents. Methods The anti-proliferative effect of ivermectin on ESCC is investigated in cell model and in nude mice model. Cell apoptosis was assessed using flow cytometry, TUNEL assay and western blotting. Mitochondrial dysfunction was determined by reactive oxygen species accumulation, mitochondrial membrane potential and ATP levels. Results Our results determined that ivermectin significantly inhibited the proliferation of ESCC cells in vitro and in vivo. Furthermore, we found that ivermectin markedly mediated mitochondrial dysfunction and induced apoptosis of ESCC cells, which indicated the anti-proliferative effect of ivermectin on ESCC cells was implicated in mitochondrial apoptotic pathway. Mechanistically, ivermectin significantly triggered ROS accumulation and inhibited the activation of NF-κB signaling pathway and increased the ratio of Bax/Bcl-2. Conclusions These finding indicated that ivermectin has significant anti-tumour potential for ESSC and may be a potential therapeutic candidate against ESCC.
first_indexed 2024-12-14T23:48:41Z
format Article
id doaj.art-dece482ee73a431e936f008dba73d37f
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-14T23:48:41Z
publishDate 2021-12-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-dece482ee73a431e936f008dba73d37f2022-12-21T22:43:19ZengBMCBMC Cancer1471-24072021-12-0121111110.1186/s12885-021-09021-xIvermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathwayNana Xu0Mengmeng Lu1Jiaxin Wang2Yujia Li3Xiaotian Yang4Xiajie Wei5Jiaoyang Si6Jingru Han7Xiaojuan Yao8Juanmei Zhang9Junqi Liu10Yanming Li11Hushan Yang12Dengke Bao13Laboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityDepartment of Radiation Oncology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Cardiology, Huaihe Hospital, Henan UniversityDepartment of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson UniversityLaboratory of Cancer Biomarkers and Liquid Biopsy, School of Pharmacy, Huaihe Hospital, Henan UniversityAbstract Background Esophageal squamous cell carcinoma (ESCC) is the most predominant primary malignant tumor among worldwide, especially in China. To date, the successful treatment remains a mainly clinical challenge, it is imperative to develop successful therapeutic agents. Methods The anti-proliferative effect of ivermectin on ESCC is investigated in cell model and in nude mice model. Cell apoptosis was assessed using flow cytometry, TUNEL assay and western blotting. Mitochondrial dysfunction was determined by reactive oxygen species accumulation, mitochondrial membrane potential and ATP levels. Results Our results determined that ivermectin significantly inhibited the proliferation of ESCC cells in vitro and in vivo. Furthermore, we found that ivermectin markedly mediated mitochondrial dysfunction and induced apoptosis of ESCC cells, which indicated the anti-proliferative effect of ivermectin on ESCC cells was implicated in mitochondrial apoptotic pathway. Mechanistically, ivermectin significantly triggered ROS accumulation and inhibited the activation of NF-κB signaling pathway and increased the ratio of Bax/Bcl-2. Conclusions These finding indicated that ivermectin has significant anti-tumour potential for ESSC and may be a potential therapeutic candidate against ESCC.https://doi.org/10.1186/s12885-021-09021-xESCCIvermectinApoptosisMitochondrialNF-κB
spellingShingle Nana Xu
Mengmeng Lu
Jiaxin Wang
Yujia Li
Xiaotian Yang
Xiajie Wei
Jiaoyang Si
Jingru Han
Xiaojuan Yao
Juanmei Zhang
Junqi Liu
Yanming Li
Hushan Yang
Dengke Bao
Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
BMC Cancer
ESCC
Ivermectin
Apoptosis
Mitochondrial
NF-κB
title Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
title_full Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
title_fullStr Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
title_full_unstemmed Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
title_short Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
title_sort ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
topic ESCC
Ivermectin
Apoptosis
Mitochondrial
NF-κB
url https://doi.org/10.1186/s12885-021-09021-x
work_keys_str_mv AT nanaxu ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT mengmenglu ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT jiaxinwang ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT yujiali ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT xiaotianyang ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT xiajiewei ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT jiaoyangsi ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT jingruhan ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT xiaojuanyao ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT juanmeizhang ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT junqiliu ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT yanmingli ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT hushanyang ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway
AT dengkebao ivermectininducesapoptosisofesophagealsquamouscellcarcinomaviamitochondrialpathway